Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chromic nitrate (chromium(III) nitrate) is an inorganic compound with the formula Cr(NO3)3. It is primarily used as a supplement to intravenous solutions for total parenteral nutrition (TPN), where it helps maintain chromium serum levels and prevent depletion of endogenous stores and subsequent deficiency symptoms[1][2]. Chromium plays a role in maintaining normal glucose metabolism and peripheral nerve function by increasing insulin binding to cells and modulating cholesterol efflux[2][8]. Chromic nitrate also finds industrial use in the preparation of chrome catalysts, textile printing operations, dyeing industry applications, pickling processes, surface treatment, and as a corrosion inhibitor[6]. Chromic nitrate is regulated as a hazardous substance due to its potential toxicity; exposure can cause irritation or burns to skin and eyes, respiratory issues if inhaled, allergic reactions on skin contact, and possible kidney damage[3]. It is not typically marketed under brand names for pharmaceutical use but may be supplied by chemical manufacturers for laboratory or industrial purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chromic nitrate.